Active Motif Secures Exclusive Global Distribution for Arima Genomics

The partnership addresses the rising demand for 3D genome mapping, a technology essential for decoding chromatin organization and complex regulatory mechanisms. By integrating Arima’s Hi-C sequencing capabilities into its existing catalog, Active Motif aims to provide researchers with a unified workflow that links epigenetic regulation with structural genome data. This expansion is designed to support investigations into cancer biology, neuroscience, and precision medicine.

Joe Fernandez, founder of Active Motif, noted that the move is intended to provide end-to-end solutions for scientists exploring the intersection of gene expression and genome architecture. Simultaneously, Arima CEO Tom Willis stated that the collaboration aligns their research-focused tools with a partner capable of managing the technical support and distribution requirements of a global market. The agreement is effective immediately, making Arima’s research portfolio available through Active Motif’s distribution network.